Table 1.
Clinical and immunohistochemical data for leiomyosarcoma and synovial sarcoma patients
| Characteristics | Cases | Survivin cytoplasm | Survivin nucleus | |||||
|---|---|---|---|---|---|---|---|---|
| IRS | 0-2 | 3-4 | 6-8 | 9-12 | 0-2 | 3-4 | 6-8 | |
| Staining | negative | weak | moderate | strong | negative | weak | moderate | |
| No. | 50 | 8 | 15 | 19 | 8 | 29 | 10 | 11 |
| Sex | ||||||||
| Male | 21 | 4 | 6 | 8 | 3 | 14 | 4 | 3 |
| Female | 29 | 4 | 9 | 11 | 5 | 15 | 6 | 8 |
| Histological subtype | ||||||||
| Leiomyosarcoma | 24 | 4 | 9 | 10 | 1 | 12 | 8 | 4 |
| Synovial sarcoma | 26 | 4 | 6 | 9 | 7 | 17 | 2 | 7 |
| Tumor grade | ||||||||
| I | 5 | 1 | 1 | 2 | 1 | 3 | 1 | 1 |
| II | 21 | 5 | 2 | 10 | 4 | 11 | 6 | 4 |
| III | 24 | 9 | 5 | 7 | 3 | 15 | 3 | 6 |
| Tumor stage | ||||||||
| stage I | 5 | 0 | 1 | 3 | 1 | 2 | 2 | 1 |
| stage II | 22 | 5 | 3 | 11 | 3 | 15 | 2 | 5 |
| stage III | 17 | 2 | 8 | 5 | 2 | 9 | 4 | 4 |
| stage IV | 6 | 1 | 3 | 0 | 2 | 3 | 2 | 1 |
| Complete resection | ||||||||
| radical (R0) | 38 | 5 | 11 | 15 | 7 | 23 | 7 | 8 |
| not radical (R1) | 12 | 3 | 4 | 4 | 1 | 6 | 3 | 3 |
| Localization | ||||||||
| extremities | 33 | 6 | 10 | 10 | 7 | 18 | 7 | 8 |
| trunc wall | 3 | 0 | 2 | 0 | 1 | 2 | 0 | 1 |
| head/neck | 2 | 1 | 0 | 1 | 0 | 2 | 0 | 0 |
| abdomen/retro- | 12 | 1 | 3 | 8 | 0 | 7 | 3 | 2 |
| peritoneum | ||||||||
| Patients follow-up | ||||||||
| alive | 18 | 2 | 6 | 7 | 3 | 10 | 6 | 2 |
| dead | 32 | 6 | 9 | 12 | 5 | 19 | 4 | 9 |